A carregar...
Improving the Stability of EGFR Inhibitor Cobalt(III) Prodrugs
[Image: see text] Although tyrosine kinase inhibitors (TKIs) have revolutionized cancer therapy in the past two decades, severe drawbacks such as strong adverse effects and drug resistance limit their clinical application. Prodrugs represent a valuable approach to overcoming these disadvantages by a...
Na minha lista:
| Publicado no: | Inorg Chem |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American
Chemical Society
2020
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7724630/ https://ncbi.nlm.nih.gov/pubmed/33222438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.inorgchem.0c03083 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|